Abiopharma

🔍 Shah Neil B. (Executive)

Company: SharkNinja, Inc. (SN)

Report Date: 2026-08-26

Detailed Transactions and Holdings:

• Sold 10,941 shares of Ordinary Shares at $185.27 per share (Direct)
  Date: 2026-08-26 | Code: S | equity_swap_involved: false | shares_owned_after: 536,279.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 39,059 shares of Ordinary Shares at $186.66 per share (Direct)
  Date: 2026-08-26 | Code: S | equity_swap_involved: false | shares_owned_after: 497,220.00 | transaction_form_type: 4 | Footnotes: F2, F3
• Holds 0 shares of Ordinary Shares (Direct)
  Date: 2026-08-26 | Code: H | Footnotes: F3

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.00 to $185.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.04 to $186.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
• F3: The amounts reported in Column 5 have been adjusted to reflect a transfer of shares by the Reporting Person to the Reporting Person's limited partnership, a correction of the number of shares originally reported as held by the Reporting Person and the Reporting Person's limited partnership on the Form 3 filed January 2, 2026, and that shares previously reported as sold by the Reporting Person directly were sold by the Reporting Person's limited partnership in the transactions dated August 7, 2026 and August 10, 2026.